Comments
Loading...
Entheon Biomedical Analyst Ratings and Price Targets | OTC:ENTBF | Benzinga
Entheon Biomedical Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Entheon Biomedical Corp from these most-recent analyst ratings.
Analyst Ratings for Entheon Biomedical
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Entheon Biomedical (ENTBF) stock?
There is no price target for Entheon Biomedical
What is the most recent analyst rating for Entheon Biomedical (ENTBF)?
There is no analyst for Entheon Biomedical
When was the last upgrade for Entheon Biomedical (ENTBF)?
There is no last upgrade for Entheon Biomedical
When was the last downgrade for Entheon Biomedical (ENTBF)?
There is no last downgrade for Entheon Biomedical.
When is the next analyst rating going to be posted or updated for Entheon Biomedical (ENTBF)?
There is no next analyst rating for Entheon Biomedical.
Is the Analyst Rating Entheon Biomedical (ENTBF) correct?
There is no next analyst rating for Entheon Biomedical.
Browse analyst ratings and price targets on all stocks.
